Nervgen Pharma (NGEN) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to - CSIMarket
CSIMarket
 


Nervgen Pharma Corp   (NGEN)


Nervgen Pharma 's ROA from the fourth quarter of 2025 to the fourth quarter of and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Nervgen Pharma 's ROA in the fourth quarter of 2025?
Nervgen Pharma Corp recorded a cumulative net loss of $-34 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -149.27%.

However, within the Healthcare sector Nervgen Pharma Corp achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the third quarter of 2025 at no. .

What is ROA?



Return On Assets (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter

Y / Y Total Assets Change 30.41 % - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -34 0 0 0 0
Return On Assets (TTM) -149.27 % 0 % 0 % 0 % 0 %
NGEN's Total Ranking # # # # #
Total Assets (TTM) in million 37 18 18 18 29
Seq. Total Assets Change 109.38 % 0 % 0 % -37.72 % -
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Assets Statistics
High Average Low
0 %
0 %
0 %
 





Financial Statements
Nervgen Pharma 's Assets $ 37 million NGEN's Balance sheet
Nervgen Pharma 's Income $ -34 million Quarterly NGEN's Income Statement
NGEN's Income by Division See NGEN's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025

FY

FY

FY

FY
Y / Y Total Assets Change - - - - -
Total Assets in million 37 0 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million -32 0 0 0 0
Annual Return On Assets -84.85 % - - - -




More Return On Assets Ratios
NGEN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NGEN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NGEN's Competitors
Subscribers only: Roa for Nervgen Pharma 's Suppliers
Subscribers only: Return On Assets for NGEN's Customers

You may also want to know
NGEN's Roi NGEN's Inventory Turnover Ratio NGEN's Growth Rates NGEN's Dividend Comparisons
NGEN's Profitability Ratios NGEN's Asset Turnover Ratio NGEN's Dividend Growth
NGEN's Roe NGEN's Valuation Ratios NGEN's Financial Strength Ratios NGEN's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA


Date modified: 2026-07-07T12:11:25+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.